Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Promoter methylation status of the tumor suppressor genes p16 and cadherin 1 in cervical intraepithelial neoplasia.

Li RN, Li CY, Lee CH, Peng CY, Wu MT.

Oncol Lett. 2017 Jun;13(6):4397-4401. doi: 10.3892/ol.2017.5975. Epub 2017 Apr 3.

2.

[Epidemiology, prevention and early detection of cervical cancer].

Wentzensen N.

Onkologe (Berl). 2016 Oct;22(10):725-736. doi: 10.1007/s00761-016-0092-7. Epub 2016 Aug 4. Scottish Gaelic.

PMID:
28265177
3.

Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma.

Wang R, van Leeuwen RW, Boers A, Klip HG, de Meyer T, Steenbergen RD, van Criekinge W, van der Zee AG, Schuuring E, Wisman GB.

Oncotarget. 2016 Dec 6;7(49):80735-80750. doi: 10.18632/oncotarget.12598.

4.

A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets.

Wijetunga NA, Pascual M, Tozour J, Delahaye F, Alani M, Adeyeye M, Wolkoff AW, Verma A, Greally JM.

Oncogene. 2017 Apr 6;36(14):2030-2044. doi: 10.1038/onc.2016.340. Epub 2016 Oct 10.

5.

Methylation pattern of CDH1 promoter and its association with CDH1 gene expression in cytological cervical specimens.

Holubeková V, Mendelová A, Grendár M, Meršaková S, Kapustová I, Jašek K, Vaňochová A, Danko J, Lasabová Z.

Oncol Lett. 2016 Oct;12(4):2613-2621. Epub 2016 Aug 12.

6.

Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.

Shen-Gunther J, Wang CM, Poage GM, Lin CL, Perez L, Banks NA, Huang TH.

Clin Epigenetics. 2016 Sep 13;8:96. doi: 10.1186/s13148-016-0263-9. eCollection 2016.

8.

A polycomb-mediated epigenetic field defect precedes invasive cervical carcinoma.

Wijetunga NA, Ben-Dayan M, Tozour J, Burk RD, Schlecht NF, Einstein MH, Greally JM.

Oncotarget. 2016 Sep 20;7(38):62133-62143. doi: 10.18632/oncotarget.11390.

9.

Novel epigenetic changes in CDKN2A are associated with progression of cervical intraepithelial neoplasia.

Wijetunga NA, Belbin TJ, Burk RD, Whitney K, Abadi M, Greally JM, Einstein MH, Schlecht NF.

Gynecol Oncol. 2016 Sep;142(3):566-73. doi: 10.1016/j.ygyno.2016.07.006. Epub 2016 Jul 9.

PMID:
27401842
10.

Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independence.

Wilting SM, Miok V, Jaspers A, Boon D, Sørgård H, Lando M, Snoek BC, van Wieringen WN, Meijer CJ, Lyng H, Snijders PJ, Steenbergen RD.

Oncotarget. 2016 Jul 12;7(28):43805-43819. doi: 10.18632/oncotarget.9698.

11.

Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women.

De Strooper LMA, Verhoef VMJ, Berkhof J, Hesselink AT, de Bruin HME, van Kemenade FJ, Bosgraaf RP, Bekkers RLM, Massuger LFAG, Melchers WJG, Steenbergen RDM, Snijders PJF, Meijer CJLM, Heideman DAM.

Gynecol Oncol. 2016 May;141(2):341-347. doi: 10.1016/j.ygyno.2016.02.012. Epub 2016 Mar 3.

12.

Human Papillomavirus Laboratory Testing: the Changing Paradigm.

Burd EM.

Clin Microbiol Rev. 2016 Apr;29(2):291-319. doi: 10.1128/CMR.00013-15. Review.

13.

DAPK1, MGMT and RARB promoter methylation as biomarkers for high-grade cervical lesions.

Sun Y, Li S, Shen K, Ye S, Cao D, Yang J.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):14939-45. eCollection 2015.

14.

DNA methylation in human papillomavirus-infected cervical cells is elevated in high-grade squamous intraepithelial lesions and cancer.

Kim MK, Lee IH, Lee KH, Lee YK, So KA, Hong SR, Hwang CS, Kee MK, Rhee JE, Kang C, Hur SY, Park JS, Kim TJ.

J Gynecol Oncol. 2016 Mar;27(2):e14. doi: 10.3802/jgo.2016.27.e14.

15.

DNA methylation markers for oral pre-cancer progression: A critical review.

Shridhar K, Walia GK, Aggarwal A, Gulati S, Geetha AV, Prabhakaran D, Dhillon PK, Rajaraman P.

Oral Oncol. 2016 Feb;53:1-9. doi: 10.1016/j.oraloncology.2015.11.012. Epub 2015 Dec 12. Review. Erratum in: Oral Oncol. 2016 Sep;60:e1.

16.

JAM3 methylation status as a biomarker for diagnosis of preneoplastic and neoplastic lesions of the cervix.

Yin A, Zhang Q, Kong X, Jia L, Yang Z, Meng L, Li L, Wang X, Qiao Y, Lu N, Yang Q, Shen K, Kong B.

Oncotarget. 2015 Dec 29;6(42):44373-87. doi: 10.18632/oncotarget.6250.

17.

Triage of high-risk human papillomavirus-positive women by methylated POU4F3.

Pun PB, Liao YP, Su PH, Wang HC, Chen YC, Hsu YW, Huang RL, Chang CC, Lai HC.

Clin Epigenetics. 2015 Aug 21;7:85. doi: 10.1186/s13148-015-0122-0. eCollection 2015.

18.

DAPK1 Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-Analysis.

Agodi A, Barchitta M, Quattrocchi A, Maugeri A, Vinciguerra M.

PLoS One. 2015 Aug 12;10(8):e0135078. doi: 10.1371/journal.pone.0135078. eCollection 2015. Review.

19.

Low fruit consumption and folate deficiency are associated with LINE-1 hypomethylation in women of a cancer-free population.

Agodi A, Barchitta M, Quattrocchi A, Maugeri A, Canto C, Marchese AE, Vinciguerra M.

Genes Nutr. 2015 Sep;10(5):480. doi: 10.1007/s12263-015-0480-4. Epub 2015 Jul 17.

20.

Triage of Atypical Glandular Cell by SOX1 and POU4F3 Methylation: A Taiwanese Gynecologic Oncology Group (TGOG) Study.

Chang CC, Ou YC, Wang KL, Chang TC, Cheng YM, Chen CH, Chu TY, Hsu ST, Liou WS, Chang YY, Wu HH, Chen TH, Lai HC.

PLoS One. 2015 Jun 9;10(6):e0128705. doi: 10.1371/journal.pone.0128705. eCollection 2015.

Supplemental Content

Support Center